CI-TROL COAGULATION CONTROLS II & III— 510(k) K771346

Substantially Equivalent

Dade, Baxter Travenol Diagnostics, Inc.

FDA 510(k) clearance K771346 for CI-TROL COAGULATION CONTROLS II & III, Substantially Equivalent on 1977-08-22. Applicant: Dade, Baxter Travenol Diagnostics, Inc.. Device class: 2.

Clearance details

Applicant
Dade, Baxter Travenol Diagnostics, Inc.
Product code
Code GGN
Device class
Class 2
Regulation
21 CFR 864.5425
Advisory panel
Hematology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Mchenry, IL, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code GGN

view all

More clearances from Dade, Baxter Travenol Diagnostics, Inc.

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.